A new podcast series from The Journal explores how a new class of drugs, led by Ozempic, is transforming bodies, fortunes and industries.
Read full story (WSJ subscription required)>
Author:
-
-
López Obrador’s final act: A radical challenge to Mexico’s democracy
-
7 U.S. troops hurt in dramatic raid that killed numerous ISIS fighters
-
Six people killed in Russian glide bomb attack in Kharkiv
-
Brazilian judge orders suspension of X in dispute with Elon Musk
-
Harris taps Minnesota Gov. Tim Walz as running mate
